Similarly, another study demonstrated that Fgf2-/- hearts have decreased cardiomyocyte hypertrophy and impaired cardiac function compared to WT mice following MI, while FGF2-overexpressing hearts showed enhanced cardiomyocyte hypertrophy and preserved function [13]. The gene discussed is FGF2; the disease is myocardial infarction.